Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Magrelli, Gianluca Azzalin, M. Salvatore, Mara Viganotti, F. Tosto, T. Colombo, R. Devito, A. Masi, A. Antoccia, S. Lorenzetti, F. Maranghi, A. Mantovani, C. Tanzarella, G. Macino, D. Taruscio (2009)
Altered microRNA Expression Patterns in Hepatoblastoma Patients.Translational oncology, 2 3
H. Fazilaty, P. Mehdipour (2014)
Genetics of breast cancer bone metastasis: a sequential multistep patternClinical & Experimental Metastasis, 31
D. Bartel (2004)
MicroRNAs Genomics, Biogenesis, Mechanism, and FunctionCell, 116
R. Nusse, H. Varmus (1982)
Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genomeCell, 31
Hangyi Yan, Xiaogang Dong, Xiaoqin Zhong, Jingwen Ye, Yun Zhou, Xiaojun Yang, Jian Shen, Jianping Zhang (2014)
Inhibitions of epithelial to mesenchymal transition and cancer stem cells‐like properties are involved in miR‐148a‐mediated anti‐metastasis of hepatocellular carcinomaMolecular Carcinogenesis, 53
Shih-Hsuan Chan, W.-C. Huang, J. Chang, K. Chang, W. Kuo, M-Y Wang, K-Y. Lin, Y. Uen, M. Hou, C-M Lin, T. Jang, C. Tu, Y.-R. Lee, Y. Lee, M. Tien, L-H Wang (2014)
MicroRNA-149 targets GIT1 to suppress integrin signaling and breast cancer metastasisOncogene, 33
Q. Wen, Jie Zhao, Lin Bai, Tongtong Wang, Haishan Zhang, Qingjie Ma (2015)
miR-126 inhibits papillary thyroid carcinoma growth by targeting LRP6.Oncology reports, 34 4
S. Liffers, J. Munding, M. Vogt, J. Kuhlmann, B. Verdoodt, S. Nambiar, A. Maghnouj, A. Mirmohammadsadegh, S. Hahn, A. Tannapfel (2011)
MicroRNA-148a is down-regulated in human pancreatic ductal adenocarcinomas and regulates cell survival by targeting CDC25BLaboratory Investigation, 91
A. Khramtsov, G. Khramtsova, M. Tretiakova, D. Huo, O. Olopade, K. Goss (2010)
Stem Cells , Tissue Engineering and Hematopoietic Elements Wnt /-Catenin Pathway Activation Is Enriched in Basal-Like Breast Cancers and Predicts Poor Outcome
Maitreyi Subramanian, S. Rao, Pooja Thacker, S. Chatterjee, D. Karunagaran (2014)
MiR‐29b Downregulates Canonical Wnt Signaling by Suppressing Coactivators of β‐Catenin in Human Colorectal Cancer CellsJournal of Cellular Biochemistry, 115
P. Polakis (2000)
Wnt signaling and cancer.Genes & development, 14 15
H. Clevers (2006)
Wnt/β-Catenin Signaling in Development and DiseaseCell, 127
R. Arend, Angelina Londoño-Joshi, J. Straughn, D. Buchsbaum (2013)
The Wnt/β-catenin pathway in ovarian cancer: a review.Gynecologic oncology, 131 3
P. Joshi, Young-Jun Jeon, A. Laganà, Justin Middleton, P. Secchiero, M. Garofalo, C. Croce (2015)
MicroRNA-148a reduces tumorigenesis and increases TRAIL-induced apoptosis in NSCLCProceedings of the National Academy of Sciences, 112
Yue Chen, Yongxi Song, Zhen-ning Wang, Zhen-yu Yue, Huimian Xu, Chengzhong Xing, Zhuangkai Liu (2010)
Altered Expression of MiR-148a and MiR-152 in Gastrointestinal Cancers and Its Clinical SignificanceJournal of Gastrointestinal Surgery, 14
Wei-guang Zhang, Chen Shen, Chenguang Li, Guang Yang, Huailei Liu, Xin Chen, Dan Zhu, Huichao Zou, Y. Zhen, Daming Zhang, Shiguang Zhao (2016)
miR‐577 inhibits glioblastoma tumor growth via the Wnt signaling pathwayMolecular Carcinogenesis, 55
Peng Liu, Hailin Tang, Bo Chen, Zhiming He, M. Deng, Minqing Wu, Xiaoping Liu, Lu Yang, Feng Ye, Xiaoming Xie (2015)
miR-26a suppresses tumour proliferation and metastasis by targeting metadherin in triple negative breast cancer.Cancer letters, 357 1
Jungeun Kim, Ying Zhang, M. Skalski, J. Hayes, B. Kefas, D. Schiff, B. Purow, S. Parsons, S. Lawler, R. Abounader (2014)
microRNA-148a is a prognostic oncomiR that targets MIG6 and BIM to regulate EGFR and apoptosis in glioblastoma.Cancer research, 74 5
R. Karim, G. Tse, T. Putti, R. Scolyer, S. Lee (2004)
The significance of the Wnt pathway in the pathology of human cancers.Pathology, 36 2
A. Serafino, N. Moroni, M. Zonfrillo, F. Andreola, L. Mercuri, G. Nicotera, J. Nunziata, R. Ricci, A. Antinori, G. Rasi, P. Pierimarchi (2014)
WNT-pathway components as predictive markers useful for diagnosis, prevention and therapy in inflammatory bowel disease and sporadic colorectal cancerOncotarget, 5
Mengtao Ma, M. He, Yan Wang, Xuyang Jiao, Lin Zhao, Xue Bai, Zhaojin Yu, Huizhe Wu, Ming Sun, Zhi Song, M. Wei (2013)
MiR-487a resensitizes mitoxantrone (MX)-resistant breast cancer cells (MCF-7/MX) to MX by targeting breast cancer resistance protein (BCRP/ABCG2).Cancer letters, 339 1
Rui Zhang, Min Li, Wen-qiao Zang, Xudong Chen, Yuan-yuan Wang, Ping Li, Yuwen Du, Guoqiang Zhao, Li Li (2013)
MiR-148a regulates the growth and apoptosis in pancreatic cancer by targeting CCKBR and Bcl-2Tumor Biology, 35
S. Gangadhara, P. Barrett-Lee, R. Nicholson, S. Hiscox (2012)
Pro-metastatic tumor-stroma interactions in breast cancer.Future oncology, 8 11
Xuefeng Bai, Zhiguo Song, Yingzi Fu, Zhaojin Yu, Lin Zhao, Haishan Zhao, W. Yao, Desheng Huang, Xiaoyi Mi, E. Wang, Zhihong Zheng, M. Wei (2012)
Clinicopathological Significance and Prognostic Value of DNA Methyltransferase 1, 3a, and 3b Expressions in Sporadic Epithelial Ovarian CancerPLoS ONE, 7
Jing-Jie Yu, Qi Li, Qing Xu, Ling-Zhi Liu, Bing-Hua Jiang (2011)
MiR-148a inhibits angiogenesis by targeting ERBB3Journal of Biomedical Research, 25
Yue-feng Chen, Yongxi Song, Zhen-ning Wang (2013)
The MicroRNA-148/152 Family: Multi-faceted PlayersMolecular Cancer, 12
Qin Xu, Yue Jiang, Yu Yin, Qi Li, Jun He, Y. Jing, Yan Qi, Qian Xu, Wei Li, Bo Lu, Stephen Peiper, B. Jiang, Ling-Zhi Liu (2013)
A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1.Journal of molecular cell biology, 5 1
B. MacDonald, K. Tamai, Xi He (2009)
Wnt/beta-catenin signaling: components, mechanisms, and diseases.Developmental cell, 17 1
Mallika Donepudi, K. Kondapalli, S. Amos, Pavithra Venkanteshan (2014)
Breast cancer statistics and markers.Journal of cancer research and therapeutics, 10 3
S. Wong, Siu Lo, K. Lee, Judy Yam, J. Chan, W. Hsiao (2002)
Expression of frizzled‐related protein and Wnt‐signalling molecules in invasive human breast tumoursThe Journal of Pathology, 196
Subsequently to the publication of the above article, an interested reader drew to the authors' attention that the data panel for the MDA‑MB‑231/migration/NC experiment in Fig. 2B on p. 1428 was strikingly similar to the data shown for the MDA‑MB‑231/invasion/Blank experiment in Fig. 2C, such that these data appeared to have been derived from the same original source. The authors have referred back to their original data, and realize that the data panel was selected incorrectly for Fig. 2B. The corrected version of Fig. 2, showing the correct data for the MDA‑MB‑231/migration/NC experiment in Fig. 2B, is shown on the next page. The authors regret the error that was made during the preparation of this figure, and can confirm that the error in the assembly of this figure did not adversely affect the conclusions reported in the study. The authors are grateful to the Editor of <em>Oncology Reports</em> for allowing them the opportunity to publish a Corrigendum, and all the authors agree to this Corrigendum. Furthermore, they apologize to the readership for any inconvenience caused. [the original article was published in Oncology Reports 35: 1425‑1432, 2016; DOI: 10.3892/or.2015.4502]
Oncology Reports – Spandidos Publications
Published: Jun 19, 2022
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.